Eucrates Biomedical Acqui...

NASDAQ: EUCRU · Real-Time Price · USD
10.02
-0.07 (-0.69%)
At close: Apr 26, 2023, 9:59 PM

Eucrates Biomedical Acquisition Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
2.42M 3.48M 3.91M 4.11M 4.77M 3.57M 2.62M 1.99M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a 76.38K 76.38K 140.78K 158.12K 81.74K 81.74K 17.34K
Other Non-Cash Items
-3.12M -4.32M -4.85M -5.03M -5.69M -4.08M -2.87M -2.12M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
68.29K 272.65K 233.35K 214.58K 240.96K 164.59K 81.74K 17.34K
Operating Cash Flow
-630.29K -573.19K -705.48K -711.19K -679.12K -345.05K -168.03K -108.01K
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 250K 250K 250K n/a n/a n/a n/a
Financial Cash Flow
-92.59M 250K 250K 250K n/a n/a n/a n/a
Net Cash Flow
-30.29K -323.19K -455.48K -461.19K -679.12K -345.05K -168.03K -108.01K
Free Cash Flow
-630.29K -573.19K -705.48K -711.19K -679.12K -345.05K -168.03K -108.01K